| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma
|
Lee, Jeeyun
|
|
2007
|
62 |
1 |
p. 77-84
|
article
|
| 2 |
A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein–Barr virus DNA as a biomarker of efficacy
|
Ma, Brigette
|
|
|
62 |
1 |
p. 59-64
|
article
|
| 3 |
A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein–Barr virus DNA as a biomarker of efficacy
|
Ma, Brigette
|
|
2007
|
62 |
1 |
p. 59-64
|
article
|
| 4 |
A randomized trial of anemia correction with two different hemoglobin targets in the first-line chemotherapy of advanced gastric cancer
|
Park, Se Hoon
|
|
2007
|
62 |
1 |
p. 1-9
|
article
|
| 5 |
Bisphosphonates induce apoptosis in CLL cells independently of MDR phenotype
|
Silva, Karina Lani
|
|
2008
|
62 |
1 |
p. 165-171
|
article
|
| 6 |
Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis
|
Logan, Richard M.
|
|
|
62 |
1 |
p. 33-41
|
article
|
| 7 |
Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis
|
Logan, Richard M.
|
|
2007
|
62 |
1 |
p. 33-41
|
article
|
| 8 |
Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer
|
Osako, Tomo
|
|
2007
|
62 |
1 |
p. 159-164
|
article
|
| 9 |
Efficacy of a nitrogen-containing bisphosphonate, minodronate, in conjunction with a p38 mitogen activated protein kinase inhibitor or doxorubicin against malignant bone tumor cells
|
Kubo, Tadahiko
|
|
2007
|
62 |
1 |
p. 111-116
|
article
|
| 10 |
In vitro evaluation of the effects of gefitinib on the modulation of cytotoxic activity of selected anticancer agents in a panel of human ovarian cancer cell lines
|
Smith, Judith A.
|
|
2007
|
62 |
1 |
p. 51-58
|
article
|
| 11 |
Mechanistic study of potentiation of chemotherapy by a haloenol lactone derivative in vitro
|
Wang, Wei
|
|
2007
|
62 |
1 |
p. 117-122
|
article
|
| 12 |
Pharmacodynamic model for chemotherapy-induced anemia in rats
|
Woo, Sukyung
|
|
2007
|
62 |
1 |
p. 123-133
|
article
|
| 13 |
Pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors: correlations with clinical characteristics and safety
|
Guo, Feng
|
|
|
62 |
1 |
p. 97-109
|
article
|
| 14 |
Pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors: correlations with clinical characteristics and safety
|
Guo, Feng
|
|
2007
|
62 |
1 |
p. 97-109
|
article
|
| 15 |
Phase 2B trial of aminopterin in multiagent therapy for children with newly diagnosed acute lymphoblastic leukemia
|
Cole, Peter D.
|
|
2007
|
62 |
1 |
p. 65-75
|
article
|
| 16 |
Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer
|
Bailey, Howard H.
|
|
2007
|
62 |
1 |
p. 149-157
|
article
|
| 17 |
Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative, for the treatment of patients with non-small cell lung cancer
|
Horti, J.
|
|
|
62 |
1 |
p. 173-180
|
article
|
| 18 |
Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative, for the treatment of patients with non-small cell lung cancer
|
Horti, J.
|
|
2008
|
62 |
1 |
p. 173-180
|
article
|
| 19 |
Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer
|
Tomonaga, Nanae
|
|
2007
|
62 |
1 |
p. 43-49
|
article
|
| 20 |
Preclinical studies of treosulfan demonstrate potent activity in Ewing’s sarcoma
|
Werner, Sebastian
|
|
2007
|
62 |
1 |
p. 19-31
|
article
|
| 21 |
Rapid complete remission in multiple myeloma with bortezomib/thalidomide/dexamethasone combination therapy following development of tumor lysis syndrome
|
Chim, C. S.
|
|
2007
|
62 |
1 |
p. 181-182
|
article
|
| 22 |
Semimechanistic pharmacokinetic/pharmacodynamic model for hepatoprotective effect of dexamethasone on transient transaminitis after trabectedin (ET-743) treatment
|
Fetterly, Gerald J.
|
|
2007
|
62 |
1 |
p. 135-147
|
article
|
| 23 |
Sequential vinorelbine–capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial
|
Ghosn, Marwan
|
|
2007
|
62 |
1 |
p. 11-18
|
article
|
| 24 |
Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme activity
|
Guarcello, Vincenzo
|
|
2007
|
62 |
1 |
p. 85-96
|
article
|
Journal description